New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - pentastarch 100 g/l (molar substitution 0.5, av. mwt 200,000 daltons); sodium chloride 9 g/l - solution for infusion - active: pentastarch 100 g/l (molar substitution 0.5, av. mwt 200,000 daltons) sodium chloride 9 g/l excipient: water for injection

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - sodium chloride - solution for infusion - %w/v

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - sodium chloride - solution for infusion

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - sodium chloride - solution for infusion

New Zealand - English - Medsafe (Medicines Safety Authority)

biomed limited - hetastarch 10%{relative} (pentastarch) - solution for injection - 10% w/v - active: hetastarch 10%{relative} (pentastarch) excipient: sodium chloride sodium hydroxide water for injection

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - hydroxyethyl starch 130/0.4 (unii: 1gvo236s58) (hydroxyethyl starch 130/0.4 - unii:1gvo236s58), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - hydroxyethyl starch 130/0.4 6 g in 100 ml - 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection is indicated for the treatment and prophylaxis of hypovolemia in adults and children. it is not a substitute for red blood cells or coagulation factors in plasma. - do not use hydroxyethyl starch (hes) products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in critically ill adult patients, including patients with sepsis, due to increased risk of mortality and renal replacement therapy (rrt).  - do not use hes products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in patients with severe liver disease. - do not use hes products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in patients with known hypersensitivity to hydroxyethyl starch [see general warnings and precautions (5.1) ] - do not use hes products in clinical conditions with volume overload.  - do not use hes products in patients with pre-existing coagulation or bleeding disorders.  - do not use h

Israel - English - Ministry of Health

cure medical & technical supply - sodium chloride; starch etherified - solution for infusion - starch etherified 60 g/l; sodium chloride 9 g/l - blood substitutes and plasma protein fractions - therapy and prophylaxis of hypovolemia, acute normovolaemic haemodilution technique.

Canada - English - Health Canada

bristol-myers squibb canada - pentastarch - solution - 10g - pentastarch 10g - replacement preparations

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - pentastarch 60 g/l (molar substitution 0.5, av. mwt 200,000 daltons); sodium chloride 9 g/l - solution for infusion - active: pentastarch 60 g/l (molar substitution 0.5, av. mwt 200,000 daltons) sodium chloride 9 g/l excipient: water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - pentastarch 100 mg/ml - solution for infusion - 10 % - active: pentastarch 100 mg/ml excipient: sodium chloride sodium hydroxide water for injection